CSF1 and central nervous system cancer: To investigate the relevance of our findings in a therapeutic treatment‐based approach, we performed survival experiments combining temozolomide (TMZ) recommended chemotherapeutic agent for glioma treatment (Furnari et al, 2007; Sathornsumetee et al, 2007) and anti‐CSF1 monoclonal antibody treatment (Fig 8A).